Screener
Northrop Grumman NOC Stand-in Attack Weapon Program — Operating Income
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Northrop Grumman in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Northrop Grumman’s 10-Q, filed July 21, 2026.
- Filed
- Jul 21, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001133421-26-000034
| $ in millions, except per share amounts | Three Months Ended June 30 / 2026 | Three Months Ended June 30 / 2025 | Six Months Ended June 30 / 2026 | Six Months Ended June 30 / 2025 |
|---|---|---|---|---|
| General and administrative expenses | 1,025 | 1,016 | 1,996 | 2,023 |
| Total operating costs and expenses | 9,780 | 9,157 | 18,672 | 18,052 |
| Gain on sale of business | — | 231 | — | 231 |
| Operating income | 1,096 | 1,425 | 2,085 | 1,998 |
| Other (expense) income | ||||
| Interest expense | (161) | (173) | (323) | (329) |
| Non-operating FAS pension benefit | 166 | 137 | 332 | 267 |
| Other, net | 67 | 38 | 104 | 69 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Northrop Grumman's stand-in attack weapon program — operating income?
- Northrop Grumman (NOC) reported stand-in attack weapon program — operating income of -$68M in Q2 2026.
- What does stand-in attack weapon program — operating income mean?
- This metric represents the profitability generated by the specific program dedicated to developing and producing stand-in attack weapon systems. It measures the operating earnings derived from contract performance, including research, development, and delivery phases of these tactical defense assets. Analyzing this figure helps investors assess the program's margin contribution and its overall impact on the company's defense systems segment performance.
Ask your AI about Northrop Grumman's stand-in attack weapon program — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude